Navigation Links
U.S. Blood Centers Pursue an Evolving Role in Cell Therapies
Date:9/26/2013

Providence, RI (PRWEB) September 26, 2013

As part of its national strategy to involve blood centers in the production and delivery of cell therapies to U.S. patients, Blood Centers of America, Inc. (BCA) announced today it will play a leadership role in representing North American independent blood centers at the upcoming two-day Stem Cells & Regenerative Medicine Congress hosted by Terrapinn starting September 30th in Cambridge, M.A.

In addition to showcasing BCA member capabilities in the event's tradeshow, BCA will be hosting one-on-one and networking meetings with senior executives of leading cell therapy and cell-based immunotherapy companies.

"The independent blood centers comprising BCA member-owners believe in a future in which they are an important partner in the preparation and delivery of cell therapies to patients,” stated BCA CEO, Bill Block. “Blood centers are a critical part of the nation’s healthcare system and cell therapy represents the next wave of healthcare innovation that we can and will support from critical biological collections, to cell processing, product manufacturing, and even administration of the products to patients.”

"BCA is a network of centers geographically dispersed throughout North America,” cites Lisa Shaffer, BCA’s Vice President of Contracts & Business Development, “with considerable experience in collecting, processing and distributing regulatory-compliant, clinical-grade biological materials. We are actively engaging cell therapy leadership in a discussion about how we can leverage BCA member infrastructure and capabilities in the development and processing of cell therapy products and their safe and cost-effective delivery to patients."

About BCA
BCA is a member-owned organization comprised of 41 independent blood centers geographically dispersed throughout the North America, providing more than 48% of the U.S. blood supply. Along with their core business of providing a substantial portion of U.S. blood supply, BCA members provide a myriad of other services in cell therapies, blood management, therapeutic apheresis, tissue and cord blood banking, etc.

BCA provides thousands of units of biological materials to life science researchers, clinicians, therapeutic companies, or companies doing medical device, diagnostic or therapeutic development work.

BCA assists cell therapy companies with securing reliable and compliant sources for the cells used in their therapeutic products and/or pre-clinical research. Where a client need exceeds the capacity of a single center, BCA can assist with putting in place a multi-center supply agreement around cell collections, processing, storage or other handling.

In 2012, BCA generated over $6 million in custom products and services to cell therapy companies including patient-donor collections for autologous cell therapies in clinical trial and commercial distribution.

For more information about BCA and its services, see http://www.bca.coop.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11159274.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Blood Centers of America Experiences Record Growth
2. Miami’s Preferred Cord Blood Laboratory, GeneCell International, Partakes in North Shore Medical Center and Hialeah Hospital’s OB/GYN Symposium
3. Blood Test on the Horizon to Detect Aortic Aneurysm and Aortic Dissection
4. Adaptive Biotechnologies Receives $2.53 million Phase II SBIR to Develop Test to Identify Cancer Patients at Risk of Death by Infection after Cord Blood Transplants
5. Case Report Suggests Microbiome Therapeutics NM504 May Improve Tolerability of Metformin While Improving Blood Glucose Control
6. China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2014
7. China Cord Blood Corporation to Report First Quarter of Fiscal 2014 Financial Results
8. ResearchMoz.us: RFID Blood Monitoring Systems (Blood Refrigerators and Freezers) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
9. Capitalizing on Opportunities in Cord Blood Industry Growth (2013 Version)
10. BCA Announces a New Member Joins Its Blood Center Coperative
11. New target for the fight against cancer as a result of excessive blood vessel formation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/7/2018)... ... November 07, 2018 , ... ... a campaign to increase awareness of the adult tissue stem cell counting problem ... of November, the company is intensifying this effort with new educational publications and ...
(Date:11/5/2018)... ... November 05, 2018 , ... Frederick ... center to increase access to science research and education in the Frederick County ... (CREST) aims to provide access to STEM-based undergraduate and graduate degree and certificate ...
(Date:11/5/2018)... ... November 05, 2018 , ... 2Blades has completed ... Like (TAL) effector code technology for applications in advancing research in epigenetic technology. ... plants. Since its discovery in 2009, the efficacy of TAL effector-based DNA targeting has ...
(Date:10/31/2018)... ... 2018 , ... Rooam , the premier payment platform for the nightlife ... its acquisition of the Tally payment app, the leading payment platform in Chicago that ... grow its market share and increase the number of restaurant and bar locations offered ...
Breaking Biology Technology:
(Date:11/20/2018)... Ontario (PRWEB) , ... November 20, 2018 , ... The ... system to track all newborn screening (NBS) specimens across the state. The ... from hospitals and delivery to the state newborn screening laboratory in Salt Lake City. ...
(Date:11/16/2018)... , ... November 16, 2018 , ... ... P.G., was awarded the International Bottled Water Association’s (IBWA’s) IBWA/Shayron Barnes-Selby Advocacy Award ... IBWA’s Advocacy Award, named “The Selby” after longtime IBWA contributor Shayron Barnes-Selby, is ...
(Date:11/15/2018)... TORONTO (PRWEB) , ... November 15, 2018 , ... Firmex ... Divestopedia. Firmex and Divestopedia surveyed over 480 investment bankers and M&A advisors worldwide to ... Dentons share their insights on the key findings in the report. , Highlights ...
Breaking Biology News(10 mins):